Drug susceptibility testing for tuberculosis based on line probe assay.

Genoscholar™ NTM+MDRTB II is approved by the World Health Organization (WHO) and distinguishes between Mycobacterium species while also testing resistance to rifampicin and isoniazid.

  • Identification of Mycobacterium species
  • Detection of resistance to rifampicin and isoniazid, based on gene mutations
  • Sample preparation from sputum or culture
  • Test results within 1 day
  • Kit contains necessary solutions/reagents for DNA amplification and DNA detection steps
  • Manual analysis or automated analyzer (Multi-Blot NS-4800)

For more information, we invite you to contact our IVD team.

Need help?
Get in touch

For information regarding Nipro products, services, and resource material: 

Give us a call
+32 15 263 500
E-mail us
Submit a detailed inquiry:
Contact per expertise
View our manufacturing locations: 
Our global network